Term
|
Definition
Single-membrane organelle present in nearly all eukaryotic cells. It contains peroxidase and catalase.
Most important event: beta-oxidation of long chain fatty acids
alpha, beta, and gamma PPAR
endogenous ligand: fatty acids, PG, leukotrienes
exogenous: drugs |
|
|
Term
Retinoid X Receptor (RXR) |
|
Definition
Ligands: retinoids
dimerizes with PPAR- doesn't matter which one you activate- either way induce generation of dimers |
|
|
Term
|
Definition
attach to nucleus response element
induce production of something
requires time (hours) |
|
|
Term
|
Definition
ligand activated transcription factors
upon binding to fatty acids or hypolipidemic drugs (fibrates), PPAR-alpa interacts with RXR and regulates the expression of target genes. These genes are involved in the catabolism of fatty acids--> lipoprotein lipase goes up--> PPAR-alpha: hyperlipidemia |
|
|
Term
|
Definition
activated by PGs, leukotrienes and anti-diabetic thiazolidinediones (glitazones?-lower sugars) and affects the expression of genes invovled in the storage of the fatty acids and others --> clinically insulin sensitivity goes up
PPAR-gamma: diabetes |
|
|
Term
|
Definition
PPAR-alpha: hyperlipidemia
clofibrate
genfibrozil (older)
fenofibrate
bezafibrate
ciprofibrate
Effects: down TGs**; down cholesterol (modest); down VLDL; up HDL; up and down LDL |
|
|
Term
|
Definition
fibrate
side effects: gall stones; LFT
Warning! when combined with statins: elevated rhabdomyolysis
displace warfarin from protein binding site |
|
|
Term
|
Definition
-glitazone
PPAR-gamma: diabetes
Troglitazone- withdrawn in 2000
Rosiglitazone
Pioglitazone
improves glycaemic control in people with Type 2 diabetes by inproving insulin sensitivity throught its action at PPAR-γ, and affects lipid metabolism through action at PPAR-γ
increase glucose transporters; lowered free fatty acids; enhanced insulin signalling; reduced TNFa; remodeling of adipose tissue
--> reducing insulin resistance
do not cause hypoglycemia
advantage over SU & repaglinide
- slow in onset (2-6) weeks
|
|
|
Term
|
Definition
monotherapy at does of 45 mg/day over 26 weeks = 2.6% reduction in HbA1c compared to placebo |
|
|
Term
|
Definition
hemoglobin is a protein in RBCs that carries O2. Hemogloin picks up glucose from the bloodstream, becoming "glycated" As blood glucose rises, so does the level of glycated hemoglobin.
Once hemoglobin becomes glycated, it remains that way for the life of the RBC, which is 3-4 months. This means the HbA1c test can provide a pictures of your glucose control over several months.
** want under 7 |
|
|
Term
|
Definition
hepatic toxicity
edema not responding to diuretics
increased circulating volume
heart failure
weight gain
paresthesias
elevations of creatinine phophokinase (CPK)
Might:
extensive hepatic metabolism
reinstate ovulation in post-menopausal women
decrease steroid levels: loss of contraceptive effect |
|
|